Skip to content

"Turkish Validation and Reliability Study of the Brompton Breathing Pattern Assessment Tool in Asthma Patients"

Validity and Reliability Study of the Turkish Version of the Brompton Breathing Pattern Assessment Tool (BPAT) in Individuals With Asthma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07450885
Acronym
BPAT-Turkish
Enrollment
101
Registered
2026-03-05
Start date
2025-07-14
Completion date
2026-04-30
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Breathing Pattern Disorder

Keywords

Brompton Breathing Pattern Assessment Tool, Turkish Version, Validity Study, Reliability Study

Brief summary

The purpose of this study is to evaluate the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT) in individuals with asthma. This study aims to determine whether the BPAT is a valid and reliable tool for assessing breathing patterns in Turkish-speaking asthma patients. The research question being addressed is: "Is the Turkish version of the BPAT a valid and reliable tool for assessing breathing patterns in individuals with asthma?"

Detailed description

This study is designed to assess the validity and reliability of the Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT). BPAT is a well-established tool used to assess the breathing patterns of individuals with respiratory conditions. In this study, a group of asthma patients will be evaluated using the BPAT to determine its applicability and consistency in the Turkish-speaking population. The reliability of the tool will be tested through repeated measurements, and its validity will be assessed by comparing BPAT results with other validated asthma assessment tools. The data will be analyzed to evaluate the internal consistency, test-retest reliability, and construct validity of the BPAT in a clinical asthma population. The linguistic validation process will be conducted following the ISPOR Task Force guidelines, including forward translation, reconciliation, back-translation, and cognitive debriefing. The psychometric properties of the tool, including internal consistency, test-retest reliability, and construct validity, will be evaluated according to the COSMIN checklist standards. Additionally, participant eligibility will be defined as individuals who are diagnosed with asthma and can understand and respond to questions in Turkish. The study will also explore any cultural adaptations necessary for the Turkish version of the BPAT to ensure its cultural relevance and accuracy in assessments.

Interventions

OTHERBrompton Breathing Pattern Assessment Tool (BPAT) - Turkish Version

A tool used to assess breathing patterns in asthma patients through clinical observation.

OTHERValidation Battery (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), Asthma Quality of Life Questionnaire (Mini AQLQ), Spirometry)

A set of validated questionnaires and objective tests used to compare with BPAT results for construct validity

Sponsors

Istanbul Saglik Bilimleri University
Lead SponsorOTHER
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Aged between 18 and 75 years * Diagnosed with severe persistent asthma according to the Global Initiative for Asthma (GINA) criteria * Turkish ethnicity * Ability to read and write in Turkish * Willingness to participate in the study

Exclusion criteria

* Having had a respiratory infection in the last 1 month * Use of oral corticosteroids in the last 4 weeks * Presence of malignancy, vasculitis, or pregnancy * Body Mass Index (BMI) \> 35 kg/m2 * Diagnosis of COPD or other primary respiratory diseases (excluding asthma) * Any musculoskeletal, neurological, or cardiovascular condition that could interfere with breathing pattern assessment or impede potential respiratory physiotherapy applications

Design outcomes

Primary

MeasureTime frameDescription
Construct Validity of the Turkish Version of the Brompton Breathing Pattern Assessment Tool (BPAT)BaselineThe study aims to evaluate the construct validity of the Turkish version of the BPAT in assessing breathing patterns among Turkish-speaking asthma patients. Validity will be determined by calculating correlation coefficients (e.g., Spearman's or Pearson's r) between the total BPAT scores, objective physiological measures (spirometry results such as FEV1 and FVC), and the scores of established reference clinical tools (Nijmegen Questionnaire, Dyspnea-12, Asthma Control Test (ACT), and Asthma Quality of Life Questionnaire (Mini-AQLQ).

Secondary

MeasureTime frameDescription
Test-Retest Reliability of the Turkish Version of BPAT7 to 14 daysThis outcome will assess the test-retest reliability of the Turkish version of BPAT by measuring the consistency of the tool in repeated assessments. The BPAT will be administered twice to the same participants. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC).
Inter-Rater Reliability of the Turkish Version of BPATBaselineThis outcome will assess the inter-rater reliability of the Turkish version of BPAT. Two independent physiotherapists will evaluate the breathing pattern of the same asthma patient. The raters will be blinded to each other's scores to determine the consistency of the tool's application between different users. Reliability will be evaluated by calculating the Intraclass Correlation Coefficient (ICC) or Cohen's Kappa.
Comparison of BPAT Results with Other Asthma Assessment ToolsBaselineDescription: This outcome will compare the BPAT results with other validated asthma assessment tools, such as Nijmegen Questionnaire, Dyspnea-12 Questionnaire , spirometry, ACT (Asthma Control Test), and Mini AQLQ (Asthma Quality of Life Questionnaire), to determine the congruence between different assessment methods.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORZuhal Kunduracılar, Prof.

Istanbul Gelisim University

STUDY_CHAIRFatma M. Tepetam, Prof.

Saglik Bilimleri Universitesi

STUDY_CHAIRŞeyma Ozden, Dr.

Saglik Bilimleri Universitesi

PRINCIPAL_INVESTIGATORDilek Unsal, PT PhD(c)

Saglik Bilimleri Universitesi

STUDY_CHAIRNisanur Tutus, PT Phd (c)

Saglik Bilimleri Universitesi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026